3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow Eczema: new trials by email Literature Review of Eczema trials Research Report on Eczema
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Dupilmuab for Atopic Dermatitis Monitored With Noninvasive Imaging. Dupilumab, Optical Coherence Tomography, Reflectance confocal microscopy - Eczema, Atopic Dermatitis | Phase 4 | Unknown | OptiSkin Medical | 15 | 2022-03-01 | 2022-03-03 |
| An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis Dupilumab Only Product - Atopic Dermatitis, AD | Phase 4 | Unknown | Eric Simpson | 45 | 2020-09-01 | 2020-08-20 |
| The Randomized Controlled Clinical Trial of Kushen Injection Compound Kushen Injection - Lung Cancer | Phase 4 | Unknown | Beijing Zheng Ju Medical Technology Co., Ltd. | 240 | 2014-11-01 | 2017-07-21 |
Dermatitis (2) · Dermatitis, Atopic (2) · Lung Neoplasms (1)
Skin Diseases (3) · Skin Diseases, Eczematous (3) · Skin and Connective Tissue Diseases (3) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Immune System Diseases (2) · Skin Diseases, Genetic (2) · Dermatitis (1) · Lung Diseases (1) · Neoplasms (1) · Neoplasms by Site (1) · Respiratory Tract Diseases (1) · Respiratory Tract Neoplasms (1)
dupilumab (2) · Tomography, Optical Coherence (1)
Beijing Zheng Ju Medical Technology Co., Ltd. (1) · Eric Simpson (1) · OptiSkin Medical (1)
China (1) · United States (1)
Eric Simspon, MD (1) · Orit Markowitz, MD (1) · Shuanghu Yuan, postdoctoral (1)